PortfoliosLab logo

Akebia Therapeutics, Inc. (AKBA)

Equity · Currency in USD · Last updated Nov 28, 2022

Company Info

ISINUS00972D1054
CUSIP00972D105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.26
Year Range$0.25 - $2.93
EMA (50)$0.30
EMA (200)$0.88
Average Volume$1.27M
Market Capitalization$47.83M

AKBAShare Price Chart


Loading data...

AKBAPerformance

The chart shows the growth of $10,000 invested in Akebia Therapeutics, Inc. in Mar 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $96 for a total return of roughly -99.04%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-30.94%
-2.56%
AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)

AKBACompare to other instruments

Search for stocks, ETFs, and funds to compare with AKBA

AKBAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-4.48%4.33%
6M-24.48%-0.78%
YTD-88.67%-15.53%
1Y-90.82%-14.36%
5Y-55.73%9.13%
10Y-41.45%9.22%

AKBAMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-11.95%8.54%-66.76%-42.20%-10.84%-4.59%10.76%-6.91%-13.19%-19.30%0.39%
202115.71%6.79%-2.17%-5.76%10.03%7.98%-34.83%19.03%-2.04%-0.35%-5.57%-16.61%
202014.24%22.85%-14.54%6.86%43.70%16.67%-17.75%-6.80%-75.89%-11.55%49.10%-15.41%
2019-0.36%32.12%12.50%-26.25%-26.32%8.76%-13.43%-1.43%-5.08%-4.85%68.63%0.48%
2018-0.61%-3.25%-33.36%-3.36%6.62%1.63%3.21%-20.29%7.55%-15.18%7.88%-31.56%
2017-3.65%-0.10%-8.18%43.26%1.67%7.24%-8.21%26.91%17.50%-7.73%-14.27%-4.43%
2016-43.27%-0.41%23.42%4.22%-5.11%-16.05%19.65%-9.16%11.32%-16.91%14.49%20.91%
2015-11.77%-9.83%19.98%-30.96%2.48%30.92%-8.65%-25.96%38.79%-7.66%20.29%20.41%
2014-26.73%24.59%-0.29%14.36%-20.33%1.67%-1.69%-41.44%-6.79%-3.64%

AKBASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Akebia Therapeutics, Inc. Sharpe ratio is -0.85. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.00JuneJulyAugustSeptemberOctoberNovember
-0.85
-0.60
AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)

AKBADividend History


Akebia Therapeutics, Inc. doesn't pay dividends

AKBADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-99.12%
-16.06%
AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)

AKBAWorst Drawdowns

The table below shows the maximum drawdowns of the Akebia Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Akebia Therapeutics, Inc. is 99.14%, recorded on Nov 17, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.14%Jun 23, 20142119Nov 17, 2022
-36.84%Mar 21, 201416Apr 11, 20145Apr 21, 201421
-21.82%Apr 22, 201420May 19, 201414Jun 9, 201434
-4.91%Jun 10, 20146Jun 17, 20143Jun 20, 20149

AKBAVolatility Chart

Current Akebia Therapeutics, Inc. volatility is 47.04%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%JuneJulyAugustSeptemberOctoberNovember
47.04%
12.31%
AKBA (Akebia Therapeutics, Inc.)
Benchmark (^GSPC)